The	O
biosyntheses	O
of	O
rosmarinic	MEDICINE
acid	MEDICINE
uses	O
4-coumaroyl-CoA	O
from	O
the	O
generalphenylpropanoid	O
pathway	O
as	O
hydroxycinnamoyl	O
donor	O
.	O
The	O
hydroxycinnamoylacceptor	O
substrate	O
comes	O
from	O
the	O
shikimate	O
pathway	O
:	O
shikimic	MEDICINE
acid	MEDICINE
,	O
quinic_acid	MEDICINE
and	O
3,4-dihydroxyphenyllactic	MEDICINE
acid	MEDICINE
derived	O
from	O
L-tyrosine	O
.	O
Thus	O
,	O
chemically	O
,	O
rosmarinic	MEDICINE
acid	MEDICINE
is	O
an	O
ester	O
of	O
caffeic	MEDICINE
acid	MEDICINE
with3,4-dihydroxyphenyllactic	MEDICINE
acid	MEDICINE
,	O
but	O
biologically	O
,	O
it	O
is	O
formed	O
from4-coumaroyl-4	O
'	O
-	O
hydroxyphenyllactate	O
.	O
Rosmarinate	O
synthase	O
is	O
an	O
enzyme	O
thatuses	O
caffeoyl-CoA	O
and	O
3,4-dihydroxyphenyllactic	MEDICINE
acid	MEDICINE
to	O
produce	O
CoA	O
androsmarinate	O
.	O
Hydroxyphenylpyruvate	O
reductase	O
is	O
also	O
an	O
enzyme	O
involved	O
inthis	O
biosynthesis	O
.	O
